A Phase 4 interventional study of atorvastatin and atorvastatin in Hypercholesterolemia, sponsored by Yonsei University. Completed at 1 site in Korea, Republic of. Per ClinicalTrials.gov, last updated 2010-03-05.
Sponsored by Yonsei University · Phase 4 and Interventional
The purpose of this study is to compare the efficacy and safety of atorvastatin generic product with reference drug.
1,238 studies on the registry are indexed under Hypercholesterolemia; 109 are open to participants now.
This study's enrollment of 17 is below the median of 99 across 991 interventional studies indexed under Hypercholesterolemia.
Browse Hypercholesterolemia studies →Yonsei University is the lead sponsor of 1,387 studies on the registry; 232 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Inclusion Criteria:
Drug: atorvastatin
Drug: atorvastatin
20 mg
Also known as: Lipinon
20 mg
Also known as: Lipitor
This study is completed, as verified in Jan 2010. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Yonsei University